Old Web
English
Sign In
Acemap
>
Paper
>
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.
2021
Karthik Ramasamy
Ajay K. Nooka
Hang Quach
Myo Htut
Rakesh Popat
Michaela Liedtke
Sascha A. Tuchman
Jacob P. Laubach
Cristina Gasparetto
Asher Chanan-Khan
Mark P. Hertzberg
Mark DeMario
Eveline Nueesch
Evelyne Chesne
Izolda Franjkovic
Katharina Lechner
Martin Kornacker
Hearn Jay Cho
Keywords:
dose escalation
Oncology
Internal medicine
Phase (matter)
BET inhibitor
in patient
Medicine
Multiple myeloma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
13
References
1
Citations
NaN
KQI
[]